JP2015120758A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015120758A5 JP2015120758A5 JP2015068513A JP2015068513A JP2015120758A5 JP 2015120758 A5 JP2015120758 A5 JP 2015120758A5 JP 2015068513 A JP2015068513 A JP 2015068513A JP 2015068513 A JP2015068513 A JP 2015068513A JP 2015120758 A5 JP2015120758 A5 JP 2015120758A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- oral administration
- dose oral
- hydrate
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- VMMKGHQPQIEGSQ-UHFFFAOYSA-N minodronic acid Chemical compound C1=CC=CN2C(CC(O)(P(O)(O)=O)P(O)(O)=O)=CN=C21 VMMKGHQPQIEGSQ-UHFFFAOYSA-N 0.000 claims 5
- 229950011129 minodronic acid Drugs 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- 239000002245 particle Substances 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 229920002785 Croscarmellose sodium Polymers 0.000 claims 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 238000000748 compression moulding Methods 0.000 claims 1
- 229960001681 croscarmellose sodium Drugs 0.000 claims 1
- 229960000913 crospovidone Drugs 0.000 claims 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 238000007922 dissolution test Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229940083542 sodium Drugs 0.000 claims 1
- 235000015424 sodium Nutrition 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2015068513A JP6142892B2 (ja) | 2011-06-20 | 2015-03-30 | 経口投与用医薬組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011136218 | 2011-06-20 | ||
| JP2011136218 | 2011-06-20 | ||
| JP2015068513A JP6142892B2 (ja) | 2011-06-20 | 2015-03-30 | 経口投与用医薬組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012138410A Division JP5874545B2 (ja) | 2011-06-20 | 2012-06-20 | 経口投与用医薬組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017031568A Division JP2017088626A (ja) | 2011-06-20 | 2017-02-22 | 経口投与用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015120758A JP2015120758A (ja) | 2015-07-02 |
| JP2015120758A5 true JP2015120758A5 (enrdf_load_stackoverflow) | 2015-08-13 |
| JP6142892B2 JP6142892B2 (ja) | 2017-06-07 |
Family
ID=47785990
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012138410A Active JP5874545B2 (ja) | 2011-06-20 | 2012-06-20 | 経口投与用医薬組成物 |
| JP2015068513A Active JP6142892B2 (ja) | 2011-06-20 | 2015-03-30 | 経口投与用医薬組成物 |
| JP2017031568A Withdrawn JP2017088626A (ja) | 2011-06-20 | 2017-02-22 | 経口投与用医薬組成物 |
| JP2018007905A Active JP6455611B2 (ja) | 2011-06-20 | 2018-01-22 | 経口投与用医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012138410A Active JP5874545B2 (ja) | 2011-06-20 | 2012-06-20 | 経口投与用医薬組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017031568A Withdrawn JP2017088626A (ja) | 2011-06-20 | 2017-02-22 | 経口投与用医薬組成物 |
| JP2018007905A Active JP6455611B2 (ja) | 2011-06-20 | 2018-01-22 | 経口投与用医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (4) | JP5874545B2 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3569642A4 (en) * | 2017-01-13 | 2020-08-12 | Nippon Paper Industries Co., Ltd. | MICROSPHERIC PARTICLES |
| US20250073205A1 (en) * | 2020-12-18 | 2025-03-06 | Daewoong Pharmaceutical Co., Ltd. | Novel formulation for oral administration, comprising 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamine |
| CN112972400A (zh) * | 2021-03-09 | 2021-06-18 | 华侨大学 | 可快速崩解的米诺膦酸颗粒及制备方法 |
| KR20230152118A (ko) | 2021-07-05 | 2023-11-02 | 치루 파머수티컬 컴퍼니 리미티드 | 약물 조성물 및 이의 제조 방법 및 용도 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4100723B2 (ja) * | 1995-07-10 | 2008-06-11 | 旭化成ケミカルズ株式会社 | 粒剤及びその製法 |
| EP0998932A1 (de) * | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
| JP4394888B2 (ja) * | 2002-02-14 | 2010-01-06 | 救急薬品工業株式会社 | 経皮投与製剤 |
| KR20140021045A (ko) * | 2002-05-10 | 2014-02-19 | 에프. 호프만-라 로슈 아게 | 골다공증 치료 및 예방용 비스포스폰산 |
| JPWO2005072747A1 (ja) * | 2004-02-02 | 2007-09-13 | 小野薬品工業株式会社 | 骨吸収抑制剤 |
| AU2006227399A1 (en) * | 2005-03-17 | 2006-09-28 | Elan Pharma International Limited | Nanoparticulate biphosphonate compositions |
| JP2007314529A (ja) * | 2006-04-28 | 2007-12-06 | Lion Corp | 造粒粒子、錠剤、及び造粒粒子の製造方法 |
| AR065096A1 (es) * | 2007-02-01 | 2009-05-13 | Takeda Pharmaceutical | Preparacion solida |
| BR112012001959A2 (pt) * | 2009-07-28 | 2016-03-15 | Takeda Pharmaceutical | comprimido,e, método para reproduzir um comprimido |
-
2012
- 2012-06-20 JP JP2012138410A patent/JP5874545B2/ja active Active
-
2015
- 2015-03-30 JP JP2015068513A patent/JP6142892B2/ja active Active
-
2017
- 2017-02-22 JP JP2017031568A patent/JP2017088626A/ja not_active Withdrawn
-
2018
- 2018-01-22 JP JP2018007905A patent/JP6455611B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20250561T1 (hr) | Formulacija valbenazina visoke doze i pripravci, postupci i pribor povezani s njima | |
| JP2018162255A5 (enrdf_load_stackoverflow) | ||
| RU2018114447A (ru) | Введение дейтерированных усилителей cftr | |
| JP2015510916A5 (enrdf_load_stackoverflow) | ||
| EA031255B1 (ru) | Состав с отсроченным высвобождением, содержащий гранулы цистеамина, и способы его получения и применения | |
| MX2015011896A (es) | Formulacion de liberacion sostenida de mosapride que proporciona efectos farmacologicos y clinicos con administracion una vez al dia. | |
| JP2016540021A5 (enrdf_load_stackoverflow) | ||
| TWI700100B (zh) | 用於口服投藥之包含依澤替米貝（ｅｚｅｔｉｍｉｂｅ）及羅舒伐他汀（ｒｏｓｕｖａｓｔａｔｉｎ）的複合調配物及其製備方法 | |
| JP2016513724A5 (enrdf_load_stackoverflow) | ||
| JP2016539953A5 (enrdf_load_stackoverflow) | ||
| SI2729130T1 (en) | Combined formulations of darunavir | |
| HRP20131088T1 (hr) | Äśvrsti farmaceutski pripravci s fiksnom dozom koji sadrže irbesartan i amlodipin, njihova priprava i terapijska primjena | |
| JP2015120758A5 (enrdf_load_stackoverflow) | ||
| CN105338970B (zh) | 包含他达拉非和坦洛新的药物胶囊复合制剂 | |
| WO2012053785A3 (ko) | 타크롤리무스를 유효성분으로 함유하는 서방형 펠렛 | |
| JP2018039810A5 (enrdf_load_stackoverflow) | ||
| JP2016530238A5 (enrdf_load_stackoverflow) | ||
| JP2016512247A5 (enrdf_load_stackoverflow) | ||
| EP3648745A4 (en) | PHARMACEUTICAL COMPOSITION WITH SPHERICAL TABLET OF MULTIPLE UNITS WITH AMEOMEPRAZOLE AND SPHERICAL PHARMACEUTICAL SALT THEREOF AND METHOD FOR MANUFACTURING THE PHARMACEUTICAL COMPOSITION | |
| IL273754B1 (en) | Fortified oral taxane preparations and methods | |
| JP2017523149A5 (enrdf_load_stackoverflow) | ||
| JP2015521647A5 (enrdf_load_stackoverflow) | ||
| JP2017520619A5 (enrdf_load_stackoverflow) | ||
| HK1218862A1 (zh) | 包含异烟肼颗粒和利福喷汀颗粒的呈包衣片剂形式的抗结核病的稳定的药物组合物及其制备方法 | |
| IN2014CN02343A (en) | Oral formulations containing hyaluronic acid for sustained drug release |